1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes as anti-infective agents

Details for Australian Patent Application No. 2006204475 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Canard, Maxime Francis Jean-Marie Ghislain; Kesteleyn, Bart Rudolf Romanie; Van De Vreken, Wim; Raboisson, Pierre Jean-Marie

Agent Shelston IP

Pub. Number AU-B-2006204475

PCT Pub. Number WO2006/072636

Priority 05100092.5 10.01.05 EP; 60/684,706 26.05.05 US

Filing date 10 January 2006

Wipo publication date 13 July 2006

Acceptance publication date 10 March 2011

International Classifications

C07D 471/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/16 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/072636 Priority application(s): WO2006/072636

10 March 2011 Application Accepted

  Published as AU-B-2006204475

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204480-Antibodies against IL-13 receptor alpha 1 and uses thereof

2006204470-Bacteriophage resistant lactic acid bacteria